ATRS

Antares Pharma News

Company Name Stock Ticker Symbol Market Type
Antares Pharma Inc ATRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 5.595 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.595 5.595
more quote information »

Recent News

Date Time Source Heading
5/26/202217:31EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:29EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:28EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:27EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:27EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:25EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:24EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:24EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:24EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:23EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202216:50EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
5/24/202216:32EDGARPost-effective Amendment to Registration Statement (pos Am)
5/24/202216:23EDGARCurrent Report Filing (8-k)
5/24/202209:08EDGARNotification Filed by National Security Exchange to Report..
5/24/202206:11EDGARAmended Tender Offer Statement by Third Party (sc To-t/a)
5/13/202216:46EDGARAmended Statement of Ownership: Solicitation (sc 14d9/a)
5/12/202208:00PRNUSHart-Scott-Rodino Waiting Period Expires for Halozyme's..
5/12/202207:13EDGARAmended Statement of Ownership: Solicitation (sc 14d9/a)
5/12/202207:02EDGARAmended Tender Offer Statement by Third Party (sc To-t/a)
5/10/202217:28EDGARQuarterly Report (10-q)
5/10/202216:42EDGARAmended Statement of Ownership: Solicitation (sc 14d9/a)
5/06/202212:10EDGARStatement of Ownership (sc 13g)
5/02/202217:08EDGARAmended Tender Offer Statement by Third Party (sc To-t/a)
5/02/202216:50BWANTARES PHARMA INVESTOR ALERT - Kuznicki Law PLLC..
5/02/202206:03EDGARStatement of Beneficial Ownership (sc 13d)
4/29/202217:56EDGARAmended Annual Report (10-k/a)
4/26/202207:17EDGARStatement of Ownership: Solicitation (sc 14d9)
4/26/202207:02EDGARTender Offer Statement by Third Party (sc To-t)
4/14/202206:10EDGARWritten Communication Relating to an Issuer or Third Party..
4/13/202217:28EDGARWritten Communication Relating to an Issuer or Third Party..
4/13/202217:27EDGARWritten Communication Relating to an Issuer or Third Party..
4/13/202209:21EDGARCurrent Report Filing (8-k)
4/13/202206:00PRNUSHalozyme to Acquire Antares Pharma to Create a Specialty..
3/29/202208:04SEEKAntares wins full FDA approval for testosterone replacement..
3/29/202207:00GLOBEAntares Pharma Announces FDA Approval Of TLANDO™, an Oral..
3/07/202208:59EDGARCurrent Report Filing (8-k)
3/07/202206:16TRMNAnalysts Are Bullish on Top Healthcare Stocks: Aclaris..
3/04/202218:39EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202218:37EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202218:35EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202208:10EDGARCurrent Report Filing (8-k)
3/03/202207:01SEEKAntares Pharma Non-GAAP EPS of $0.02 beats by $0.01, revenue..
3/03/202207:00GLOBEAntares Pharma Reports Fourth Quarter and Full-Year 2021..
3/02/202211:49SEEKAntares Pharma Q4 2021 Earnings Preview
2/28/202208:30GLOBEAntares Pharma to Present at the Cowen 42nd Annual..
2/17/202208:30GLOBEAntares Pharma To Report Fourth Quarter And Full-Year 2021..
2/14/202209:08EDGARStatement of Ownership (sc 13g)
2/03/202209:26SEEKAntares resubmitted NDA for testosterone replacement therapy..
2/03/202208:00GLOBEAntares Pharma Announces FDA Acceptance of NDA Resubmission..
2/01/202217:16EDGARAmended Statement of Ownership (sc 13g/a)


Your Recent History
NASDAQ
ATRS
Antares Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now